Related Experiment Videos
[Coronary risk and prescription in primary care patients with hypercholesterolemia]
M V Bonné Moreno1, O González Löwenberg, E Charques Velasco
1Centro de Salud Mar Báltico, Madrid.
Insights
High coronary risk (CR) is prevalent in hypercholesterolemia patients. Lipid-lowering treatment effectively reduced CR in high-risk individuals after one year.
Area of Science:
- Cardiology
- Public Health
- Internal Medicine
Background:
- Hypercholesterolemia is a significant risk factor for cardiovascular disease.
- Assessing and managing coronary risk (CR) is crucial in patient care.
Purpose of the Study:
- To determine the prevalence of high CR in hypercholesterolemia patients.
- To evaluate current lipid-lowering treatment practices.
- To assess changes in CR after treatment.
Main Methods:
- Cross-sectional study in primary care settings.
- Inclusion of 583 hypercholesterolemia patients (both sexes, >25 years).
- Utilized the Framingham coronary multivariate risk method for CR assessment.
Main Results:
- 32.5% of patients without prior cardiovascular events had CR > 20%.
- High CR patients were more likely to receive lipid-lowering treatment.
- Treatment led to a significant reduction in CR for high-risk individuals (28.7% relative difference).
Conclusions:
- A substantial proportion of hypercholesterolemia patients face high coronary risk.
- Lipid-lowering treatment is associated with high CR and family history.
- Effective management strategies can lower coronary risk in this population.
Objective:
In patients with hypercholesterolaemia determinate the prevalence of high coronary risk (CR), study the lipid lowering treatment applied and determinate if there is any change in CR after a period of treatment.
Design:
Cross-sectional.
Emplacement:
Primary care.
Patients:
583 patients with hypercholesterolaemia both sex, older than 25 years registered in chronic mobility, randomized selected.
Measurement And Results:
Applying the Framingham coronary multivariate risk method we estimate high CR > 20%. Patients with a previous history of cardiovascular event, were treated in a 50%, more frequently younger subjects, rising 220 mg/dl of final cholesterol level. Patients without any cardiovascular event known, the 32.5% (28.0-36.7%) have a CR > 20%. Subjects with high CR have 4.9 (3.0-8.2) more probability if receiving treatment than the others with lower risk. The lipid-lowering treatment is explained in a 67% because the high CR and the family history of coronary event. After at least one year period there is a reduction in those with high CR (difference relative of proportions 28.7% [20.4-37.1]).